Case number 1:19-cv-01295
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cadila Healthcare Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 27, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the Consent Judgment filed at D.I. 434 in Lead Case No. 18-1689-CFC. Associated Cases: 1:18-cv-01763-CFC-SRF, 1:19-cv-01295-CFC, 1:19-cv-01501-CFC(nmf) |
| Aug 21, 2019 | 18 | SO ORDERED (6) Docket Text: SO ORDERED, re (79 in 1:18-cv-01689-CFC-SRF, 12 in 1:19-cv-01295-CFC) Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. C.A. No. 19-1295 (CFC) shall be consolidated with C.A. No. 18-1689 (CFC)( consolidated) for all purposes, and all papers shall be filed in C.A. No. 18-1689 (CFC)( consolidated); Signed by Judge Colm F. Connolly on 8/21/2019. Associated Cases: 1:18-cv-01689-CFC-SRF, 1:19-cv-01295-CFC(fms) |
| Aug 21, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01689-CFC-SRF. ALL PAPERS SHALL BE FILED in C.A. No. 18-1689 (CFC)( consolidated) (fms) |
| Aug 16, 2019 | 17 | Answer to Counterclaim (23) Docket Text: ANSWER to [6] Answer to Complaint, Counterclaim by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 16, 2019 | 16 | Certification of Brett Garrison (1) |
| Aug 16, 2019 | 16 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brett Garrison - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # (1) Certification of Brett Garrison)(Bilson, David) |
| Aug 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brett M. Garrison for Cadila Healthcare Limited and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] STIPULATION TO EXTEND TIME for Plaintiffs to file their Answer to Defendants' Counterclaims (D.I. 6) to August 16, 2019 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 8/16/2019. (fms) |
| Aug 16, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Brett Garrison filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 8/16/2019. (fms) |
| Aug 15, 2019 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to file their Answer to Defendants' Counterclaims (D.I. 6) to August 16, 2019 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Aug 14, 2019 | 14 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Rule 26(a)(1) Initial Disclosures for C.A. No. 19-1295-CFC; and (2) Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery for C.A. No. 19-1295-CFC filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc..(Bilson, David) |
| Aug 13, 2019 | 13 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Rule 26(a) Initial Disclosures and (2) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard for Discovery, Including Discovery of Electronically Stored Information (ESI) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Aug 9, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ryan A. Cook, Chad A. Landmon, Jonathan M. Knowles, Edward M. Mathias for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Aug 9, 2019 | 12 | Stipulation (6) Docket Text: STIPULATION and Proposed Order Regarding Consolidation of Cases by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Aug 8, 2019 | 11 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 4(a) of the Default Standard For Discovery Including Discovery of Electronically Stored Information ("ESI") filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan) |
| Jul 24, 2019 | 10 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before August 21, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: Notice of Compliance deadline set for 8/21/2019. Signed by Judge Colm F. Connolly on 7/24/2019. (nmf) |
| Jul 23, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Chad A. Landmon, Edward M. Mathias, Ryan A. Cook and Jonathan M. Knowles filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited. Signed by Judge Colm F. Connolly on 7/23/2019. (fms) |
| Jul 23, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Chad A. Landmon, Edward M. Mathias, Ryan A. Cook and Jonathan M. Knowles - filed by Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Jul 17, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jul 17, 2019 | 6 | Answer to Complaint (27) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Limited.(Phillips, John) |
| Jul 17, 2019 | 7 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Limited. (Phillips, John) |
| Jul 17, 2019 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cadila Healthcare Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) |
| Jul 12, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Cadila Healthcare Limited on 7/12/2019; Zydus Pharmaceuticals (USA) Inc. on 7/12/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Jul 11, 2019 | 1 | Main Document (20) Docket Text: COMPLAINT - filed against Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2683706.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-5, # (2) Civil Cover Sheet) (lak) |
| Jul 11, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. (lak) |
| Jul 11, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ;7,713,938 B2 ;8,551,957 B2 ;9,949,998 B2 ;10,258,637 B2. (lak) |
| Jul 11, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/30/2019. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/1/2022. (lak) |
| Jul 11, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Jul 11, 2019 | 1 | Civil Cover Sheet (1) |
| Jul 11, 2019 | 1 | Exhibit 1-5 (186) |
| Jul 11, 2019 | 1 | Complaint* (1) |
